A patient with metastatic bladder cancer has had an ongoing 9-year complete remission on a clinical trial of immunotherapy with nivolumab and ipimumab, but he also was following an intensive dietary and nutritional supplement regimen. Whether this combination or the immunotherapy alone brought about his good outcome is unknown but could be clarified in future trials by improved data collection about dietary and supplement choices.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
complete remission
8
clinical trial
8
metastatic bladder
8
bladder cancer
8
missing trial
4
trial variable
4
variable case
4
case report
4
report dietary
4
dietary modification
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!